- Home
- JVA vs IMNN Comparison
JVA vs IMNN Comparison
Compare JVA & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- IMNN
- Stock Information
- Founded
- JVA 1971
- IMNN 1982
- Country
- JVA United States
- IMNN United States
- Employees
- JVA N/A
- IMNN N/A
- Industry
- JVA Packaged Foods
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- IMNN Health Care
- Exchange
- JVA Nasdaq
- IMNN Nasdaq
- Market Cap
- JVA 14.7M
- IMNN 15.1M
- IPO Year
- JVA 2005
- IMNN 1985
- Fundamental
- Price
- JVA $2.98
- IMNN $1.02
- Analyst Decision
- JVA
- IMNN Strong Buy
- Analyst Count
- JVA 0
- IMNN 2
- Target Price
- JVA N/A
- IMNN $21.50
- AVG Volume (30 Days)
- JVA 181.9K
- IMNN 244.7K
- Earning Date
- JVA 10-18-2024
- IMNN 11-12-2024
- Dividend Yield
- JVA N/A
- IMNN N/A
- EPS Growth
- JVA N/A
- IMNN N/A
- EPS
- JVA 0.20
- IMNN N/A
- Revenue
- JVA $76,111,698.00
- IMNN N/A
- Revenue This Year
- JVA N/A
- IMNN N/A
- Revenue Next Year
- JVA N/A
- IMNN N/A
- P/E Ratio
- JVA $13.96
- IMNN N/A
- Revenue Growth
- JVA 17.27
- IMNN N/A
- 52 Week Low
- JVA $0.67
- IMNN $0.48
- 52 Week High
- JVA $3.88
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- JVA 53.73
- IMNN 45.13
- Support Level
- JVA $2.69
- IMNN $0.99
- Resistance Level
- JVA $3.12
- IMNN $1.08
- Average True Range (ATR)
- JVA 0.26
- IMNN 0.05
- MACD
- JVA -0.07
- IMNN 0.00
- Stochastic Oscillator
- JVA 27.62
- IMNN 50.00
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in the business of wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada and certain countries in Asia.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.